Everywhere I go chords Amy Grant



Literature on the chapter on dementia (sometimes only shown directly as a link in the chapter). Depending on the journal, not all articles are freely available in full text. Journals such as the BMJ have all articles free, some journals require registration and then only have older articles freely available. Articles are freely available to subscribers after registering with all magazines.


    1. Mahyar Etminan, Sudeep Gill, and Ali Samii, Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studiesBMJ 2003; 327: 128. [Abstract] [Abridged text] [Abridged PDF] [Full text] [PDF]
    2. A. D. Smith Imaging the progression of Alzheimer's pathology through the brain PNAS, April 2, 2002; 99 (7): 4135 - 4137. [Full Text] [PDF]
    3. A. P. Porsteinsson, P. N. Tariot, R. Erb, C. Cox, E. Smith, L. Jakimovich, J. Noviasky, N. Kowalski, C. J. Holt, and C. Irvine Placebo-Controlled Study of Divalproex Sodium for Agitation in Dementia Am. J. Geriatr. Psychiatry, February 1, 2001; 9 (1): 58-66. [Abstract] [Full Text]
    4. A. Stevens, R. Milne, R. Lilford, and J. Gabbay Keeping pace with new technologies: systems needed to identify and evaluate them BMJ, November 13, 1999; 319 (7220): 1291-1291. [Full Text]
    5. Abdel-sayed WS, Toppozada HK, Said SA, El-sayed OK. Some metabolic and hormonal changes in women using long acting injectable contraceptives. Alex J Pharm Sci. 1989; 3: 29-32. MEDLINE
    6. Abraham, W. C., Logan, B., Greenwood, J. M., Dragunow, M. (2002). Induction and Experience-Dependent Consolidation of Stable Long-Term Potentiation Lasting Months in the Hippocampus. J. Neurosci. 22: 9626-9634 [Abstract] [Full Text]
    7. Ahmed, S., Mozley, P.D., Potter, W. Z. (2002). Biomarkers in Psychotropic Drug Development. AJGP 10: 678-686 [Abstract] [Full Text]
    8. Aisen, PS, Egelko, S., Andrews, H., Diaz-Arrastia, R., Weiner, M., DeCarli, C., Jagust, W., Miller, JW, Green, R., Bell, K., Sano, M. (2003). A Pilot Study of Vitamins to Lower Plasma Homocysteine ​​Levels in Alzheimer's Disease. AJGP 11: 246-249 [Abstract] [Full Text]
    9. Andrieu et al. Association of Alzheimer's Disease Onset With Ginkgo Biloba and Other Symptomatic Cognitive Treatments in a Population of Women Aged 75 Years and Older From the EPIDOS Study J Gerontol A Biol Sci Med Sci 2003; 58: M372-377. ABSTRACT | FULL TEXT
    10. Ang-Lee et al. Herbal Medicines and Perioperative Care JAMA 2001; 286: 208-216.ABSTRACT | FULL TEXT
    11. Astin Complementary and Alternative Medicine and the Need for Evidence-based Criticism Acad Med 2002; 77: 864-868. FULL TEXT
    12. B. LAWLOR Managing behavioral and psychological symptoms in dementia Br. J. Psychiatry, December 1, 2002; 181 (6): 463 - 465. [Full Text] [PDF]
    13. B. Pitt Coping with loss: Loss in late life BMJ, May 9, 1998; 316 (7142): 1452-1454. [Full Text]
    14. Bartels, et al. Evidence-Based Practices in Geriatric Mental Health Care PS 2002; 53: 1419-1431. ABSTRACT | FULL TEXT
    15. Bartels, S. J., Dums, A. R., Oxman, T. E., Schneider, L. S., Arean, P. A., Alexopoulos, G. S., Jeste, D. V. (2002). Evidence-Based Practices in Geriatric Mental Health Care. PS 53: 1419-1431 [Abstract] [Full Text]
    16. Bernabei Review: Ginkgo biloba extract improves cognitive function in mild to moderate Alzheimer's disease Evid Based Ment Health 1999; 2: 82-82. FULL TEXT
    17. Biegon, A., Alvarado, M., Budinger, T. F., Grossman, R., Hensley, K., West, M. S., Kotake, Y., Ono, M., Floyd, R. A. (2002). Region-selective effects of neuroinflammation and antioxidant treatment on peripheral benzodiazepine receptors and NMDA receptors in the rat brain. J Neurochem 82: 924-934 [Abstract] [Full Text]
    18. Birkenhäger WH, Forette F, Seux ML, Wang JG, Staessen JA. Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med. 2001; 161: 152-156.
      Breteler MMB. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging. 2000; 21: 153-160. MEDLINE
    19. Borroni, B., Agosti, C., Panzali, A.F., Di Luca, M., Padovani, A., Miller, J.W., Green, R., Mungas, D.M., Reed, B.R., Jagust, W.J. (2002). Homocysteine, vitamin B6, and vascular disease in patients with AD. Neurology 59: 1475-1476 [Full Text]
    20. Boutaud, O., Ou, J.J., Chaurand, P., Caprioli, R.M., Montine, T.J., Oates, J.A. (2002). Prostaglandin H2 (PGH2) accelerates formation of amyloid {beta} 1-42 oligomers. J Neurochem 82: 1003-1006 [Abstract] [Full Text]
    21. Bowen RL, Isley JP, Atkinson RL. An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol. 2000; 12: 351-354. MEDLINE
    22. Bowen RL, Smith MA, Harris PL, et al. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res. 2002; 70: 514-518. MEDLINE
    23. Braak, H. & Braak, E. (1991) Acta Neuropathologica 82, 239-259
    24. Breitner, J. C.S., Zandi, P.P. (2001). Do Nonsteroidal Antiinflammatory Drugs Reduce the Risk of Alzheimer's Disease ?. N Engl J Med 345: 1567-1568 [Full Text]
    25. Brenner DE, Kukull WA, Stergachis A, et al. Postmenopausal estrogen therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol. 1994; 140: 262-267. MEDLINE
    26. Buccafusco and Terry Multiple Central Nervous System Targets for Eliciting Beneficial Effects on Memory and Cognition J. Pharmacol. Exp. Ther. 2000; 295: 438-446. ABSTRACT | FULL TEXT
    27. Burggren, A. C., Small, G. W., Sabb, F. W., Bookheimer, S. Y. (2002). Specificity of Brain Activation Patterns in People at Genetic Risk for Alzheimer Disease. AJGP 10: 44-51 [Abstract] [Full Text]
    28. Buttini, M., Yu, G.-Q., Shockley, K., Huang, Y., Jones, B., Masliah, E., Mallory, M., Yeo, T., Longo, FM, Mucke, L . (2002). Modulation of Alzheimer-Like Synaptic and Cholinergic Deficits in Transgenic Mice by Human Apolipoprotein E Depends on Isoform, Aging, and Overexpression of Amyloid beta Peptides But Not on Plaque Formation. J. Neurosci. 22: 10539-10548 [Abstract] [Full Text]
    29. C, Samsioe G, Lidfelt J, Nerbrand C, Agardh CD. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. Menopause. 2000; 7: 273-281. MEDLINE
    30. C. G. Lyketsos, O. Lopez, B. Jones, A. L. Fitzpatrick, J. Breitner, and S. DeKosky Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment: Results From the Cardiovascular Health Study JAMA, September 25, 2002; 288 (12): 1475 - 1483. [Abstract] [Full Text] [PDF]
    31. Calabrese Psycho 28/2002
    32. Chang, L., Speck, O., Miller, E.N., Braun, J., Jovicich, J., Koch, C., Itti, L., Ernst, T. (2001). Neural correlates of attention and working memory deficits in HIV patients. Neurology 57: 1001-1007 [Abstract] [Full Text]
    33. Christians Oxidative stress and Alzheimer's disease1 Am. J. Clin. Nutr. 2000; 71: 621s-629.ABSTRACT | FULL TEXT
    34. D. Melzer Personal paper: New drug treatment for Alzheimer's disease: lessons for healthcare policy BMJ, March 7, 1998; 316 (7133): 762-764. [Full Text]
    35. Day, M., Morris, R.G.M., Shimizu, E., Tang, Y.-P., Rampon, C., Feng, R., Shrom, D., Tsien, J. Z. (2001). Memory Consolidation and NMDA Receptors: Discrepancy Between Genetic and Pharmacological Approaches. Science 293: 755a-755 [Full Text]
    36. De Bree, A., Verschuren, W. M. M., Kromhout, D., Kluijtmans, L. A. J., Blom, H. J. (2002). Homocysteine ​​Determinants and the Evidence to What Extent Homocysteine ​​Determines the Risk of Coronary Heart Disease. Pharmacological Reviews 54: 599-618 [Abstract] [Full Text]
    37. De Deyn PP, Rabheru K, Rasmussen A, Bocksberger JP, Dautzenberg PL, Eriksson S, Lawlor BA, Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry. 1999 Feb; 60 (2): 107-15
    38. DE LA TORRE, J.C. (2002). Vascular Basis of Alzheimer's Pathogenesis. Annals NYAS Online 977: 196-215 [Abstract] [Full Text]
    39. den Heijer, T., Vermeer, S. E, Clarke, R., Oudkerk, M., Koudstaal, P. J., Hofman, A., Breteler, M. M. B. (2002). Homocysteine ​​and brain atrophy on MRI of non-demented elderly. Brain 126: 170-175 [Abstract] [Full Text]
    40. Di Ciano, P., Cardinal, R.N., Cowell, R.A., Little, S.J., Everitt, B.J. (2001). Differential Involvement of NMDA, AMPA / Kainate, and Dopamine Receptors in the Nucleus Accumbens Core in the Acquisition and Performance of Pavlovian Approach Behavior. J. Neurosci. 21: 9471-9477 [Abstract] [Full Text]
    41. Dik, M. G., Jonker, C., Comijs, H. C., Bouter, L. M., Twisk, J. W.R., van Kamp, G. J., Deeg, D. J.H. (2001). Memory complaints and APOE- {epsilon} 4 accelerate cognitive decline in cognitively normal elderly. Neurology 57: 2217-2222 [Abstract] [Full Text]
    42. Elevated Homocysteine ​​Is a Risk Factor for Alzheimer's Disease. Journal Watch Neurology 2002: 4-4 [Full Text]
    43. Eric M. Reiman, Richard J. Caselli, Kewei Chen, Gene E. Alexander, Daniel Bandy, and Jennifer Frost Declining brain activity in cognitively normal apolipoprotein E. 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease PNAS 2001 98: 3334-3339. [Abstract] [Full Text] [PDF]
    44. Ernst and Cohen Informed Consent in Complementary and Alternative Medicine Arch Intern Med 2001; 161: 2288-2292. FULL TEXT
    45. Ernst, T., Chang, L., Jovicich, J., Ames, N., Arnold, S. (2002). Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology 59: 1343-1349 [Abstract] [Full Text]
    46. Evers, M. R., Salmen, B., Bukalo, O., Rollenhagen, A., Bosl, M. R., Morellini, F., Bartsch, U., Dityatev, A., Schachner, M. (2002). Impairment of L-type Ca2 + Channel-Dependent Forms of Hippocampal Synaptic Plasticity in Mice Deficient in the Extracellular Matrix Glycoprotein Tenascin-C. J. Neurosci. 22: 7177-7194 [Abstract] [Full Text]
    47. Fabiszewski KJ, Volicer B, Volicer L. Effect of antibiotic treatment on outcome of fevers in institutionalized Alzheimer patients. JAMA. 1990; 263: 3168-3172. MEDLINE
    48. Fazel, S. (2002). Increased plasma total homocysteine ​​levels increased the risk for dementia in the elderly. Evid Based Med 7: 160-160 [Full Text]
    49. Foley, D.J., Masaki, K., White, L., Redline, S., Mignot, E., Murphy, Jr, G.M., Young, T. (2001). Relationship Between Apolipoprotein E {epsilon} 4 and Sleep-Disordered Breathing at Different Ages. JAMA 286: 1447-1448 [Full Text]
    50. Françoise Forette et al, The Prevention of Dementia With Antihypertensive Treatment, New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study Arch Intern Med. 2002; 162: 2046-2052
    51. Fratiglioni L, Ahlbom A, Viitanen M, Winblad B. Risk factors for late-onset Alzheimer's disease: a population-based, case-control study. Ann Neurol. 1993; 33: 258-266. MEDLINE
    52. Fratiglioni L, De Ronchi D, Agüero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging. 1999; 15: 365-375. MEDLINE
    53. Frenchman IB, Prince T. Clinical experience with risperidone, haliperidal and thioridazine for dementia-associated behavioral distubances. Int Psychogeriatr 9 (4): 431-5 (Dec. 1997)
    54. FRISONI, G B (2001). Structural imaging in the clinical diagnosis of Alzheimer's disease: problems and tools. J. Neurol. Neurosurg. Psychiatry 70: 711-718 [Full Text]
    55. Fugh-Berman and Cott Dietary Supplements and Natural Products as Psychotherapeutic Agents Psychosom Med 1999; 61: 712-728. ABSTRACT | FULL TEXT
    56. G. T. Grossberg and A. K. Desai Management of Alzheimer's Disease J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2003; 58 (4): M331 - 353. [Full Text] [PDF]
    57. Garibotto, G., Sofia, A., Saffioti, S., Russo, R., Deferrari, G., Rossi, D., Verzola, D., Gandolfo, M. T., Sala, M. R. (2003). Interorgan exchange of aminothiols in humans. At the. J. Physiol. 284: E757-763 [Abstract] [Full Text]
    58. Gary W. Small, Linda M. Ercoli, Daniel H. S. Silverman, S.-C. Huang, Scott Komo, Susan Y. Bookheimer, Helen Lavretsky, Karen Miller, Prabha Siddarth, Natalie L. Rasgon, John C. Mazziotta, Sanjaya Saxena, HM Wu, Michael S. Mega, Jeffrey L. Cummings, Ann M. Saunders, Margaret A. Pericak-Vance, Allen D. Roses, Jorge R. Barrio, and Michael E. Phelps
      From the Cover: Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
      PNAS 2000 97: 6037-6042; published online before print as 10.1073 / pnas.090106797 [Abstract] [Full Text] [PDF]
    59. Gayatri Devi, MD; Ruth Ottman, PhD; Ming-Xin Tang, PhD; Karen Marder, MD, MPH; Yaakov Stern, PhD; Richard Mayeux, MD, MSc Familial Aggregation of Alzheimer Disease Among Whites, African Americans, and Caribbean Hispanics in Northern Manhattan January 2000ABSTRACT | FULL TEXT | PDF
    60. Geerlings MI, Ruitenberg A, Witteman JCM, et al. Reproductive period and risk of dementia in postmenopausal women.
      JAMA. 2001; 285: 1475-1481.ABSTRACT | FULL TEXT | PDF
    61. George S. Alexopoulos, M.D. Jonathan M. Silver, M.D. David A. Kahn, M.D. Allen Frances, M.D. Daniel Carpenter, Ph.D The Expert Consensus Guideline Series, Treatment of Agitation in Older Persons with Dementia Editors for the Guidelines,. www.psychguides.com/index.html
    62. Goodman, A.B., Pardee, A.B. (2003). Evidence for defective retinoid transport and function in late onset Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 100: 2901-2905 [Abstract] [Full Text]
    63. Gossen, M., Bujard, H. (2002). STUDYING GENE FUNCTION IN EUKARYOTES BY CONDITIONAL GENE INACTIVATION. Annu. Rev. Genet. 36: 153-173 [Abstract] [Full Text]
    64. Grady D, Herrington D, Bittner V, et al, for the HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen / progestin Replacement Study follow-up (HERS II). JAMA. 2002; 288: 49-57. ABSTRACT | FULL TEXT | PDF | MEDLINE
    65. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992; 117: 1016-1036. MEDLINE
    66. Greenberg, S. M. (2002). Cerebral amyloid angiopathy and dementia: Two amyloids are worse than one. Neurology 58: 1587-1588 [Full Text]
    67. Greicius, M D, Geschwind, M D, Miller, B L (2002). Presenile dementia syndromes: an update on taxonomy and diagnosis. J. Neurol. Neurosurg. Psychiatry 72: 691-700 [Abstract] [Full Text]
    68. Greicius, M D, Geschwind, M D, Miller, B L (2002). Presenile dementia syndromes: an update on taxonomy and diagnosis. J. Neurol. Neurosurg. Psychiatry 72: 691-700 [Abstract] [Full Text]
    69. Grossberg and Desai Management of Alzheimer's Disease J Gerontol A Biol Sci Med Sci 2003; 58: M331-353.FULL TEXT
    70. Hachinski V. Vascular dementia: the need for a new approach. J Intern Med. 1997; 242: 277-279. MEDLINE
    71. Han, Q., Xu, M., Tang, L., Tan, X., Tan, X., Tan, Y., Hoffman, R.M. (2002). Homogeneous, Nonradioactive, Enzymatic Assay for Plasma Pyridoxal 5-Phosphate. Clin Chem 48: 1560-1564 [Abstract] [Full Text]
    72. Hariri, A. R, Weinberger, D. R (2003). Imaging genomics. Br Med Bull 65: 259-270 [Abstract] [Full Text]
    73. Helene Benveniste, Gillian Einstein, Katie R. Kim, Christine Hulette, and G. Allan Johnson Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy
      PNAS 1999 96: 14079-14084. [Abstract] [Full Text] [PDF]
    74. Henderson VW, Paganini-Hill A, Miller BL, et al. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology. 2000; 54: 295-301. MEDLINE
    75. Hock C, Konietzko U, Streffer JR, Tracy J, Signorell A, Muller-Tillmanns B, Lemke U, Henke K, Moritz E, Garcia E, Wollmer MA, Umbricht D, de Quervain DJ, Hofmann M, Maddalena A, Papassotiropoulos A. , Nitsch RM., Antibodies against beta-amyloid Slow Cognitive Decline in Alzheimer's Disease. Neuron. 2003 May 22; 38 (4): 547-54
    76. Homocysteine ​​- Risk Factor for Alzheimer's Disease ?. Journal Watch Psychiatry 2002: 10-10 [Full Text]
    77. Homocysteine ​​- Risk Factor for Alzheimer's Disease ?. Journal Watch (General) 2002: 1-1 [Full Text]
    78. Hulley S, Grady D, Bush T, et al, for the Heart and Estrogen / progesterone Replacement Study (HERS) Research Group.Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998; 280: 605-613. ABSTRACT | FULL TEXT | PDF | MEDLINE
    79. Husaini, B.A., Moonis, M., Levine, R. (2003). Dementia and Hormone Use. PS 54: 575-575 [Full Text]
    80. Iadecola, C., Gorelick, P.B. (2003). Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia. Stroke 34: 335-337 [Full Text]
    81. J. F. Reilly, D. Games, R. E. Rydel, S. Freedman, D. Schenk, W. G. Young, J. H. Morrison, and F. E. Bloom Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model PNAS, April 15, 2003; 100 (8): 4837 - 4842. [Abstract] [Full Text] [PDF]
    82. Jack, CR, Petersen, RC, Xu, Y., O'Brien, PC, Smith, GE, Ivnik, RJ, Boeve, BF, Tangalos, EG & Kokmen, E. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD (2000) Neurology 55, 484-489
    83. Jakubowski, H. (2002). Homocysteine ​​Is a Protein Amino Acid in Humans. IMPLICATIONS FOR HOMOCYSTEINE-LINKED DISEASE. J. Biol. Chem. 277: 30425-30428 [Abstract] [Full Text]
    84. K. Scott, R. M. Lawrence, A. Duggal, C. Darwin, E. Brooks, and G. Christodoulou Prescribing patterns for psychotic and behavioral symptoms in dementia: a national survey Psychiatr. Bull., August 1, 2002; 26 (8): 288 - 290. [Abstract] [Full Text] [PDF]
    85. Kapur, N., Kopelman, M. D (2003). Advanced brain imaging procedures and human memory disorder. Br Med Bull 65: 61-81 [Abstract] [Full Text]
    86. Kato, T., Knopman, D., Liu, H. (2001). Dissociation of regional activation in mild AD during visual encoding: A functional MRI study. Neurology 57: 812-816 [Abstract] [Full Text]
    87. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging, Neurology. 1997; 48: 1517-1521, MEDLINE
    88. Kelly, C.A., Harvey, R.J. & Cayton, H. (1997) Drug treatments for Alzheimer's disease Br. Med. J. 314, 693-694
    89. Knable Extract of Ginkgo biloba added to haloperidol was effective for positive symptoms in refractory schizophrenia Evid Based Ment Health 2002; 5: 90-90.
    90. Korczyn, A.D. (2002). Homocysteine, Stroke, and Dementia. Stroke 33: 2343-2344 [Full Text]
    91. Krause, BJ, Schmidt, D., Mottaghy, FM, Taylor, J., Halsband, U., Herzog, H., Tellmann, L. & Muller-Gartner, HW Episodic retrieval activates the precuneus irrespective of the imagery content of word pair associates A PET study (2001) Brain 122, 255-263
    92. Landi, F., Cesari, M., Onder, G., Russo, A., Torre, S., Bernabei, R. (2003). Non-Steroidal Anti-Inflammatory Drug (NSAID) Use and Alzheimer Disease in Community-Dwelling Elderly Patients. AJGP 11: 179-185 [Abstract] [Full Text]
    93. LeBlanc ES, Janowsky J, Chan BKS, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA. 2001; 285: 1489-1499. ABSTRACT | FULL TEXT | PDF
    94. Leveille SG, LaCroix AZ, Newton KM, Keenan NL. Older women and hormone replacement therapy: factors influencing late life initiation. J Am Geriatr Soc. 1997; 45: 1496-1500. MEDLINE
    95. Levine, B, Cabeza, R, McIntosh, A R, Black, S E, Grady, C L, Stuss, D T (2002). Functional reorganization of memory after traumatic brain injury: a study with H2150 positron emission tomography. J. Neurol. Neurosurg. Psychiatry 73: 173-181 [Abstract] [Full Text]
    96. Levine, J., Stahl, Z., Sela, B. A., Gavendo, S., Ruderman, V., Belmaker, R. H. (2002). Elevated Homocysteine ​​Levels in Young Male Patients With Schizophrenia. At the. J. Psychiatry 159: 1790-1792 [Abstract] [Full Text]
    97. Li, S.-J., Li, Z., Wu, G., Zhang, M.-J., Franczak, M., Antuono, P. G. (2002). Alzheimer's Disease: Evaluation of a Functional MR Imaging Index as a Marker. Radiology 225: 253-259 [Abstract] [Full Text]
    98. Loeb C, Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia.Stroke. 1983; 14: 399-401. MEDLINE
    99. Lokk, J. (2003). News and Views on Folate and Elderly Persons. J Gerontol A Biol Sci Med Sci 58: M354-361 [Abstract] [Full Text]
    100. Lovestone, S (2002). Can we afford to develop treatments for dementia ?. J. Neurol. Neurosurg. Psychiatry 72: 685-685 [Full Text]
    101. Luchsinger, J.A., Tang, M.-X., Shea, S., Mayeux, R. (2003). Antioxidant Vitamin Intake and Risk of Alzheimer's Disease. Arch Neurol 60: 203-208 [Abstract] [Full Text]
    102. MJ de Leon, A. Convit, OT Wolf, CY Tarshish, S. DeSanti, H. Rusinek, W. Tsui, E. Kandil, AJ Scherer, A. Roche, A. Imossi, E. Thorn, M. Bobinski, C Caraos, P. Lesbre, D. Schlyer, J. Poirier, B. Reisberg, and J. Fowler Prediction of cognitive decline in normal elderly subjects with 2- [18F] fluoro-2-deoxy-D-glucose / positron emission tomography (FDG / PET) PNAS 2001 98: 10966-10971; published online before print as 10.1073 / pnas.191044198 [Abstract] [Full Text] [PDF]
    103. M. Lepage, O. Ghaffar, L. Nyberg, and E. Tulving From the Cover: Prefrontal cortex and episodic memory retrieval mode PNAS January 4, 2000; 97 (1): 506 - 511. [Abstract] [Full Text] [PDF]
    104. M.J. DeLeon, T. Crook: The Global Deterioration Scale for assessment of primary degenerative dementia. At the. J. Psychiatry, 139, 1136-1139 (1982).)
    105. Madeline Murguia Rice, PhD; Amy Borenstein Graves, PhD; Susan M. McCurry, PhD; Laura E. Gibbons, PhD; Jim D. Bowen, MD; Wayne C. McCormick, MD; Eric B. Larson, MD, MPH Arch Intern Med. 2000; 160: 1641-1649
    106. Maidment The use of ginkgo biloba in the treatment of dementia Psychiatr Bull 2001; 25: 353-356. ABSTRACT | FULL TEXT
    107. Marquis, S., Moore, M. M., Howieson, D. B., Sexton, G., Payami, H., Kaye, J. A., Camicioli, R. (2002). Independent Predictors of Cognitive Decline in Healthy Elderly Persons. Arch Neurol 59: 601-606 [Abstract] [Full Text]
    108. Mattson, M.P. (2003). Will caloric restriction and folate protect against AD and PD ?. Neurology 60: 690-695 [Abstract] [Full Text]
    109. Mattson, M.P., Duan, W., Guo, Z. (2003). Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms. J Neurochem 84: 417-431 [Abstract] [Full Text]
    110. Mayeux and Sano Treatment of Alzheimer's Disease N Engl J Med 1999; 341: 1670-1679. FULL TEXT
    111. Mayeux, R., Small, S.A. (2000). Finding the Beginning or Predicting the Future ?. Arch Neurol 57: 783-784 [Full Text]
    112. Mazurek, A.A., De Deyn, P.P., Mayeux, R., Sano, M. (2000). Treatment of Alzheimer's Disease. N Engl J Med 342: 821-822 [Full Text]
    113. Mega, M.S., Small, G. W., Xu, M. L., Felix, J., Manese, M., Tran, N. P., Dailey, J. I., Ercoli, L. M., Bookheimer, S. Y., Toga, A. W. (2002). Hippocampal Atrophy in Persons With Age-Associated Memory Impairment: Volumetry Within a Common Space. Psychosom Med 64: 487-492 [Abstract] [Full Text]
    114. Merrill F. Elias, PhD, MPH; Alexa Beiser, PhD; Philip A. Wolf, MD; Rhoda Au, PhD; Roberta F. White, PhD; Ralph B. D'Agostino, PhD The Preclinical Phase of Alzheimer Disease: A 22-Year Prospective Study of the Framingham Cohort http://archneur.ama-assn.org/issues/v57n6/abs/noc90027.html Arch Neurol. 2000; 57: 808-813
    115. Miller, B. L. (2002). Past Glory and Future Promise: Maximizing and Improving Understanding of Atrophy Patterns in the Diagnosis of Degenerative Dementias. AJNR Am J Neuroradiol 23: 33-34 [Full Text]
    116. Miller, J. W., Selhub, J., Nadeau, M. R., Thomas, C. A., Feldman, R. G., Wolf, P. A. (2003). Effect of L-dopa on plasma homocysteine ​​in PD patients: Relationship to B-vitamin status. Neurology 60: 1125-1129 [Abstract] [Full Text]
    117. Montine, T.J., Milatovic, D., Gupta, R.C., Valyi-Nagy, T., Morrow, J.D., Breyer, R.M. (2002). Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent. J Neurochem 83: 463-470 [Abstract] [Full Text]
    118. Morley, J. E. (2003). Editorial: Hot Topics in Geriatrics. J Gerontol A Biol Sci Med Sci 58: M30-36 [Full Text]
    119. Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C., Wilson, R.S. (2002). Vitamin E and Cognitive Decline in Older Persons. Arch Neurol 59: 1125-1132 [Abstract] [Full Text]
    120. Morrison RS, Siu AL. Mortality from pneumonia and hip fractures in patients with advanced dementia [letter]. JAMA. 2000; 284: 2447-2448. FULL TEXT | PDF | MEDLINE
    121. Morrison RS, Siu AL. Survival in end-stage dementia following acute illness. JAMA. 2000; 284: 47-52. ABSTRACT | FULL TEXT | PDF | MEDLINE
    122. MRI Aids in Diagnosis of Early Alzheimer's Disease. Journal Watch Psychiatry 2000: 5-5 [Full Text]
    123. Mueggler, T., Sturchler-Pierrat, C., Baumann, D., Rausch, M., Staufenbiel, M., Rudin, M. (2002). Compromised Hemodynamic Response in Amyloid Precursor Protein Transgenic Mice. J. Neurosci. 22: 7218-7224 [Abstract] [Full Text]
    124. Mulnard RA, Cotman CW, Kawas C, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer's disease. JAMA. 2000; 283: 1007-1015 ABSTRACT | FULL TEXT
    125. Nahin and Straus Research into complementary and alternative medicine: problems and potential BMJ 2001; 322: 161-164. FULL TEXT
    126. Neugroschl, J., Davis, K.L. (2002). Biological Markers in Alzheimer's Disease. AJGP 10: 660-677 [Abstract] [Full Text]
    127. New Treatments for Alzheimer's Disease Reviewed. Journal Watch Neurology 2000: 3-3 [Full Text]
    128. Nobili, F., Koulibaly, M., Vitali, P., Migneco, O., Mariani, G., Ebmeier, K., Pupi, A., Robert, PH, Rodriguez, G., Darcourt, J. (2002 ). Brain Perfusion Follow-Up in Alzheimer's Patients During Treatment with Acetylcholinesterase Inhibitors. J Nucl Med 43: 983-990 [Abstract] [Full Text]
    129. NSAID Use and Risk for Alzheimer's Disease. Journal Watch (General) 2001: 2-2 [Full Text]
    130. NSAID Use and Risk for Alzheimer's Disease. Journal Watch Psychiatry 2002: 9-9 [Full Text]
    131. O. L. Lopez, S. R. Wisniewski, J. T. Becker, F. Boller, and S. T. DeKosky Psychiatric Medication and Abnormal Behavior as Predictors of Progression in Probable Alzheimer Disease Arch Neurol, October 1, 1999; 56 (10): 1266 - 1272. [Abstract] [Full Text] [PDF]
    132. O'Hara et al. Update on Alzheimer's disease: recent findings and treatments eWJM 2000; 172: 115-120.FULL TEXT
    133. Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer's disease. Arch Neurol 1998; 55: 1409-1415
    134. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol. 1994; 140: 256-261. MEDLINE
    135. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer's disease. Arch Intern Med. 1996; 156: 2213-2217. MEDLINE
    136. Pantano, P., Iannetti, G. D., Caramia, F., Mainero, C., Di Legge, S., Bozzao, L., Pozzilli, C., Lenzi, G. L. (2002). Cortical motor reorganization after a single clinical attack of multiple sclerosis. Brain 125: 1607-1615 [Abstract] [Full Text]
    137. Pedreira, M. E., Perez-Cuesta, L. M., Maldonado, H. (2002). Reactivation and Reconsolidation of Long-Term Memory in the Crab Chasmagnathus: Protein Synthesis Requirement and Mediation by NMDA-Type Glutamatergic Receptors. J. Neurosci. 22: 8305-8311 [Abstract] [Full Text]
    138. Peskind, E.R., Wilkinson, C.W., Petrie, E.C., Schellenberg, G.D., Raskind, M.A. (2001). Increased CSF cortisol in AD is a function of APOE genotype.